| For: | Hernandez-Alejandro R, Croome KP, Drage M, Sela N, Parfitt J, Chandok N, Marotta P, Dale C, Wall W, Quan D. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma. World J Gastroenterol 2012; 18(31): 4145-4149 [PMID: 22919246 DOI: 10.3748/wjg.v18.i31.4145] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i31/4145.htm |
| Number | Citing Articles |
| 1 |
Peter J. Altshuler, Hien Dang, Adam M. Frank, Ashesh P. Shah, Jaime Glorioso, Tingting Zhan, Arturo Rios Diaz, Osama Shaheen, Carlo B. Ramirez, Warren R. Maley, Adam S. Bodzin. Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. Liver Transplantation 2022; 28(4) doi: 10.1002/lt.26313
|
| 2 |
Rocío Llorca, Jorge Funuyet, Manuel Romero-Gómez. Cirrhosis is less cirrhosis without virus C. Annals of Hepatology 2013; 12(2) doi: 10.1016/S1665-2681(19)31377-8
|
| 3 |
Masamichi Hayashi, Suguru Yamada, Hiroshi Tanabe, Hideki Takami, Yoshikuni Inokawa, Fuminori Sonohara, Dai Shimizu, Norifumi Hattori, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. High Serum Uric Acid Levels Could Be a Risk Factor of Hepatocellular Carcinoma Recurrences. Nutrition and Cancer 2021; 73(6) doi: 10.1080/01635581.2020.1779758
|
| 4 |
Lorenzo A. Orci, Marco Sanduzzi-Zamparelli, Berta Caballol, Victor Sapena, Nicola Colucci, Ferran Torres, Jordi Bruix, María Reig, Christian Toso. Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression. Clinical Gastroenterology and Hepatology 2022; 20(2) doi: 10.1016/j.cgh.2021.05.002
|
| 5 |
Trevor W Reichman, George Therapondos, Maria-Stella Serrano, John Seal, Rachel Evers-Meltzer, Humberto Bohorquez, Ari Cohen, Ian Carmody, Emily Ahmed, David Bruce, George E Loss. “Weighing the risk”: Obesity and outcomes following liver transplantation. World Journal of Hepatology 2015; 7(11): 1484-1493 doi: 10.4254/wjh.v7.i11.1484
|
| 6 |
Aleksandra Berkan-Kawińska, Anna Piekarska. Hepatocellular carcinoma in non-alcohol fatty liver disease – changing trends and specific challenges. Current Medical Research and Opinion 2020; 36(2) doi: 10.1080/03007995.2019.1683817
|
| 7 |
Rohit Kohli, Shikha Sunduram, Marialena Mouzaki, Sabina Ali, Pushpa Sathya, Stephanie Abrams, Stavra A. Xanthakos, Miriam Vos, Jeffrey B. Schwimmer. Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON). The Journal of Pediatrics 2016; 172 doi: 10.1016/j.jpeds.2015.12.016
|
| 8 |
Jihane N. Benhammou, Elizabeth S. Aby, Gayaneh Shirvanian, Kohlett Manansala, Shehnaz K. Hussain, Myron J. Tong. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66507-7
|
| 9 |
Gabriel De la Cruz Ku, Matthew Aizpuru, Hubert Hackl, Daniel S. Ubl, Elizabeth B. Habermann, Ron Pery, Michael Driedger, Alice Assinger, David M. Nagorney, Sean P. Cleary, Rory L. Smoot, Patrick Starlinger. Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality. HPB 2022; 24(9) doi: 10.1016/j.hpb.2022.02.009
|
| 10 |
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Gut 2023; 72(1) doi: 10.1136/gutjnl-2021-324915
|
| 11 |
Yan-Wen Liu, Chih-Chi Wang, Yueh-Wei Liu, Wei-Feng Li, Yi-Hao Yen, Yuan-Hung Kuo, Hsin-Ming Wang, Ming-Chao Tsai. Concurrent Steatotic Liver Disease and Prognosis After Curative Resection of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S577506
|
| 12 |
Matthew L. Holzner, Sander Florman, Myron E. Schwartz, Parissa Tabrizian. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma. HPB 2022; 24(4) doi: 10.1016/j.hpb.2021.08.943
|
| 13 |
Avi Toiv, Abdulmalik Saleem, Mark Obri, Gorden Jacobsen, Adarsh Varma, Reena Salgia, Syed-Mohammed R. Jafri. Retrospective Study of Liver Transplant Recipients Over 69: Clinical Features and Outcomes of a Growing Group. Transplantation Proceedings 2025; 57(6) doi: 10.1016/j.transproceed.2025.05.033
|
| 14 |
Darren Hiu-Sun Foog, Deborah Kwok, Becky Ching-Yeung Yu, Vincent Wai-Sun Wong. Managing HCC in NAFLD. Current Hepatology Reports 2017; 16(4) doi: 10.1007/s11901-017-0376-4
|
| 15 |
Jie Ning Yong, Wen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, Jieling Xiao, Phoebe Wen Lin Tay, Snow Yunni Lin, Nicholas Syn, Nicholas Chew, Benjamin Nah, Yock Young Dan, Daniel Q. Huang, Eunice Xiang Xuan Tan, Arun J. Sanyal, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D. Muthiah. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review. Clinical Gastroenterology and Hepatology 2023; 21(1) doi: 10.1016/j.cgh.2021.11.014
|
| 16 |
Ryan M. Gill, Sanjay Kakar. Nonalcoholic Steatohepatitis. Surgical Pathology Clinics 2013; 6(2) doi: 10.1016/j.path.2013.03.002
|
| 17 |
Sara M. Lewin, Neil Mehta, R. Kate Kelley, John P. Roberts, Francis Y. Yao, Danielle Brandman. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transplantation 2017; 23(8) doi: 10.1002/lt.24764
|
| 18 |
Kunlin Chen, Ming Yang, Guangjun Li, Wentao Wang, Yun-Wen Zheng. Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis. PLOS ONE 2025; 20(3) doi: 10.1371/journal.pone.0317730
|
| 19 |
Hua Qu, Hang Wang, Min Deng, Huili Wei, Huacong Deng, Partha Mukhopadhyay. Associations between Longer Habitual Day Napping and Non-Alcoholic Fatty Liver Disease in an Elderly Chinese Population. PLoS ONE 2014; 9(8) doi: 10.1371/journal.pone.0105583
|
| 20 |
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2) doi: 10.3390/biomedicines11020586
|
| 21 |
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos-Molina. Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy response. Metabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.64
|
| 22 |
Carrie R Wong, Mindie H Nguyen, Joseph K Lim. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(37): 8294-8303 doi: 10.3748/wjg.v22.i37.8294
|
| 23 |
Beatriz Castelló, Victoria Aguilera, M. Teresa Blázquez, Ángel Rubín, María García, Carmen Vinaixa, Salvador Benlloch, Fernando SanJuan, Eva Montalva, Rafael López, Marina Berenguer. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis. Annals of Hepatology 2019; 18(6) doi: 10.1016/j.aohep.2019.06.014
|
| 24 |
Elliot B. Tapper, Charlotte Fleming, Adriana Rendon, João Fernandes, Pierre Johansen, Margarida Augusto, Sunita Nair. The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies. Gastro Hep Advances 2022; 1(6) doi: 10.1016/j.gastha.2022.06.016
|
| 25 |
Alessandro Parente, Flavio Milana, Shahin Hajibandeh, Shahab Hajibandeh, Krishna V. Menon, Ki-Hun Kim, A. M. James Shapiro, Andrea Schlegel. Liver transplant for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease versus other etiologies: A meta-analysis. Digestive and Liver Disease 2025; 57(2) doi: 10.1016/j.dld.2024.09.025
|
| 26 |
Jonathan Merola, AnnMarie Liapakis, David C. Mulligan, Peter S. Yoo. Non‐alcoholic fatty liver disease following liver transplantation: a clinical review. Clinical Transplantation 2015; 29(9) doi: 10.1111/ctr.12585
|
| 27 |
Srinevas K. Reddy, David A. Geller. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; doi: 10.1016/B978-0-323-34062-5.00071-6
|
| 28 |
Jonathan G. Stine, Brian J. Wentworth, Alex Zimmet, Mary E. Rinella, Rohit Loomba, Stephen H. Caldwell, Curtis K. Argo. Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases. Alimentary Pharmacology & Therapeutics 2018; 48(7) doi: 10.1111/apt.14937
|
| 29 |
Tomomi Kogiso, Katsutoshi Tokushige. The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma. Cancers 2021; 13(3) doi: 10.3390/cancers13030516
|
| 30 |
Liat Ninio, Abraham Nissani, Tomer Meirson, Tom Domovitz, Alessandro Genna, Shams Twafra, Kolluru D. Srikanth, Roba Dabour, Erez Avraham, Ateret Davidovich, Hava Gil-Henn, Meital Gal-Tanamy. Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation. Cells 2019; 8(11) doi: 10.3390/cells8111395
|
| 31 |
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
|